BRIEF published on 11/10/2026 at 18:35, 4 days 8 hours ago Predilife: 2026 Half-Year Results and Financial Challenges Revenue Half-year Results Judicial Reorganization MammoRisk FDA Denseerisk
BRIEF published on 07/16/2026 at 18:05, 3 months 29 days ago PREDILIFE's semi-annual liquidity contract review as of June 30, 2026 Liquidity Transactions Actions PREDILIFE Half-year Review
BRIEF published on 07/02/2026 at 18:05, 4 months 12 days ago Termination of the liquidity contract between PREDILIFE and TSAF Liquidity Contract Termination Euronext Growth TSAF PREDILIFE
BRIEF published on 07/01/2026 at 18:05, 4 months 13 days ago Results of the PREDILIFE General Meeting Capital Artificial Intelligence General Assembly PREDILIFE Resolutions Adopted
BRIEF published on 06/29/2026 at 20:05, 4 months 15 days ago Predilife: Update on the FDA procedure and 2025 financial report FDA Artificial Intelligence Financial Report Judicial Reorganization PREDILIFE
BRIEF published on 06/02/2026 at 08:05, 5 months 12 days ago Predilife: 2025 Review and Advances in Predictive Medicine Cancer Screening 2025 Financial Results Restructuring Strategy FDA Denseerisk Personalized Prediction
BRIEF published on 04/07/2026 at 08:05, 7 months 7 days ago Predilife outlines its strategy to maximize its industrial and financial potential Treasury PREDILIFE MammoRisk Industrial Strategy Risk Prediction
BRIEF published on 03/02/2026 at 19:05, 8 months 12 days ago PREDILIFE is making progress in submitting DenSeeRisk to the FDA FDA PREDILIFE MammoRisk Breast Cancer DenSeeRisk
BRIEF published on 01/16/2026 at 18:05, 9 months 29 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 12/17/2025 at 18:35, 10 months 28 days ago Major validation of the MammoRisk strategy against breast cancer PREDILIFE MammoRisk Breast Cancer Personalized Screening WISDOM Study
Published on 11/14/2026 at 12:56, 14 hours 37 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 2 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 2 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 2 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 3 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 4 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 5 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 8 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 18:04, 1 day 9 hours ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Published on 11/13/2026 at 11:35, 1 day 15 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/12/2026 at 23:12, 2 days 4 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 2 days 8 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 2 days 9 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 17:40, 2 days 9 hours ago Financial information for the period ended 30 September 2026
